Participants 109 126 6
in ovarian cancer
Participants 350 378 7
Patients with stage IC-IV OC
Participants 884 911 3
. PD or death in 636 patien
Participants 1045 1246 8
S Randomized induction therapy was received by 820 of 919 patients enrolled; 352 patients with CR received paclitaxel consolidation whereas 155 patients without CR received single-agent crossover thera
